Journal article
Adenoma recurrence after piecemeal colonic EMR is predictable: the Sydney EMR recurrence tool
DJ Tate, L Desomer, A Klein, G Brown, LF Hourigan, EYT Lee, A Moss, D Ormonde, S Raftopoulos, R Singh, SJ Williams, S Zanati, K Byth, MJ Bourke
Gastrointestinal Endoscopy | MOSBY-ELSEVIER | Published : 2017
Abstract
Background and Aims EMR is the primary treatment of large laterally spreading lesions (LSLs) in the colon. Residual or recurrent adenoma (RRA) is a major limitation. We aimed to identify a robust method to stratify the risk of RRA. Methods Prospective multicenter data on consecutive LSLs ≥20 mm removed by piecemeal EMR from 8 Australian tertiary-care centers were included (September 2008 until May 2016). A logistic regression model for endoscopically determined recurrence (EDR) was created on a randomly selected half of the cohort to yield the Sydney EMR recurrence tool (SERT), a 4-point score to stratify the incidence of RRA based on characteristics of the index EMR. SERT was validated on t..
View full abstractGrants
Funding Acknowledgements
D. Tate received a scholarship from the Westmead Medical Research Foundation. These funds were not used for this study. The Cancer Institute New South Wales provided funding for a research nurse and data manager to assist with the administration of the study. There was no influence from the Institution regarding study design or conduct, data collection, management, analysis or interpretation, preparation, review, or approval of the manuscript. All other authors disclosed no financial relationships relevant to this publication.